Syndax Pharmaceuticals In... (SNDX)
NASDAQ: SNDX
· Real-Time Price · USD
11.02
-0.18 (-1.56%)
At close: Jun 04, 2025, 10:03 AM
-1.56% (1D)
Bid | 11.06 |
Market Cap | 948.24M |
Revenue (ttm) | 43.72M |
Net Income (ttm) | -331.2M |
EPS (ttm) | -3.85 |
PE Ratio (ttm) | -2.86 |
Forward PE | -4.05 |
Analyst | Buy |
Ask | 11.1 |
Volume | 59,028 |
Avg. Volume (20D) | 2,582,935 |
Open | 11.27 |
Previous Close | 11.20 |
Day's Range | 11.00 - 11.41 |
52-Week Range | 8.58 - 25.07 |
Beta | 0.74 |
About SNDX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SNDX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SNDX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+7.47%
Syndax Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
3 months ago
-1.02%
Syndax Pharmaceuticals shares are trading lower after the company reported Q4 financial results and missed its EPS and sales estimate.

4 weeks ago · seekingalpha.com
Syndax Pharmaceuticals, Inc. (SNDX) Q1 2025 Earnings Call TranscriptSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX ) Q1 2025 Earnings Conference Call May 5, 2025 4:30 PM ET Company Participants Sharon Klahre - Head of IR Michael Metzger - Chief Executive Officer and Direct...